💊
Adstiladrin
nadofaragene firadenovec
Non-Muscle Invasive Bladder Neoplasms
✅ Authorised
Advanced therapy
✅
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Adstiladrin is indicated as monotherapy for the treatment of adult patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours.
⚠️ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/adstiladrin